ResearcherShinshu University HospitalNo recent work listed

Ryu Yanagisawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4012-0958; OpenAlex author ID A5030299290. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study. Co-author DOI 10.21873/anticanres.12464 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Masato Okamoto · 1 shared paper, 2018 · strength 0.08
- Paper WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study. DOI 10.21873/anticanres.12464 ↗
Shigetaka Shimodaira · 1 shared paper, 2018 · strength 0.08
- Paper WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study. DOI 10.21873/anticanres.12464 ↗
Shigeo Koido · 1 shared paper, 2018 · strength 0.08
- Paper WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study. DOI 10.21873/anticanres.12464 ↗
Kazuhiro Nagai · 1 shared paper, 2018 · strength 0.08
- Paper WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study. DOI 10.21873/anticanres.12464 ↗
Haruo Sugiyama · 1 shared paper, 2018 · strength 0.08
- Paper WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study. DOI 10.21873/anticanres.12464 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.